Navigation Links
FDA Clears the Pathwork(R) Tissue of Origin Test for Hard-To-Identify Tumors
Date:7/31/2008

Pathwork Diagnostics' Gene Expression Test Is the First to Receive FDA Clearance for Diagnosis of Uncertain Tumors; Problem Affects 200,000 New

U.S. Cancer Cases Annually

SUNNYVALE, Calif., July 31 /PRNewswire/ -- Pathwork Diagnostics, Inc., a molecular diagnostics company focused on oncology, today announced that the U.S. Food and Drug Administration (FDA) has cleared its Pathwork(R) Tissue of Origin Test for use in determining the origin of uncertain tumors. The test analyzes a tumor's gene expression pattern to help pinpoint the source of hard-to-identify tumors and is the first test of its kind to receive FDA clearance. Up to an estimated 200,000 newly diagnosed cancer patients annually in the U.S. may have a tumor for which the site of origin is uncertain after the initial diagnostic workup.(1,2,3,4) The FDA's clearance underscores the growing role that patients' genomic information can play in helping physicians make better decisions.

"Knowing the primary tumor site with greater certainty enables more appropriate cancer treatment. The growing trend in cancer care is the use of therapies that target specific tissues and their genomic components, rather than relying on a one-size-fits-all treatment approach," said Deborah J. Neff, President and Chief Executive Officer of Pathwork Diagnostics. "We believe the Pathwork Tissue of Origin Test will help provide more certainty in tumor diagnosis, which will enable more patients to realize the benefits of this new era in genomics-based diagnostics." The FDA-cleared Pathwork Tissue of Origin Test will be available as an in vitro diagnostic (IVD) kit, meaning that clinical laboratories can run the test themselves. The test is currently available as a service through Pathwork's CLIA-certified laboratory.

The Pathwork Tissue of Origin Test uses a microarray to measure the expression pattern, comprising more than 1,500 genes, in the uncertain tumor and compares it to e
'/>"/>

SOURCE Pathwork Diagnostics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. FDA Clears ExAblate Fertility Enhancement Study in Women With Uterine Fibroids
2. FDA Clears Advanced Test for Monitoring Metastatic Colorectal Cancer
3. Childrens Brain Tumor Foundations Tissue Bank Consortium May Solve Dire Problem in Pediatric Cancer Research
4. Newly Published Study Shows OPKOs siRNA Bevasiranib Is Taken Up by Target Tissues in the Eye
5. Phase I/II Study of Targeted Gene Delivery In Vivo - Intravenous Infusions of REXIN-G - Demonstrates Dose-Dependent Anti-Tumor Activity Without Toxicity in Patients With Progressive Chemo-Resistant Bone and Soft Tissue Sarcoma (ASCO 2008)
6. Cardium and Tissue Repair Companys Excellarate Candidate for Healing Diabetic Wounds Gains Media Focus in Multiple Regions Across U.S.
7. Study Finds Starion Instruments Tissue Welding Technology Safe and Effective in Parotidectomy Procedures
8. Knee Pain? An Exclusive Study Engineers Cartilage to Match Patients Own Tissue
9. Study of Pathwork Diagnostics Tissue of Origin Test Published in the Journal of Molecular Diagnostics: Investigates Test Reproducibility in Multiple Labs to Determine Primary Tumor in Cancer Cases
10. Raydiance Collaborates With Rutgers University and Nations Largest Tissue Bank to Develop Innovative Tissue Processing Approaches
11. Study Finds Starion Instruments Tissue Welding Technology Reduces Pain and Bleeding in Tonsillectomy Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/29/2015)...  Dr. Yair Walzer has added a leading ... often caused by menopause. The MonaLisa Touch™, an in-office procedure ... clearance in 2014. Dr. Walzer is one of the first ... special fractional CO 2 laser specifically designed to help ... In 2010 there were greater than 46M women between ...
(Date:5/29/2015)... 2015 LifeNet Health plans to enlarge its ... to more than 160 people. The organization,s ... Health,s innovative bio-implants, which are being made more widely ... served. It also is a reflection of the region,s ... growth and success of LifeNet Health is a great ...
(Date:5/29/2015)... and MENLO PARK, Calif. ... DelMar Pharmaceuticals, Inc. (OTCQX: DMPI) ("DelMar" and ... and commercializing proven cancer therapies in new orphan ... American Association of Cancer Research (AACR) Advances ... potential for its lead product candidate VAL-083 ...
Breaking Medicine Technology:The Newest FDA-Cleared Breakthrough In Women's Health Treatments 2LifeNet Health to add more than 160 jobs in 2015 2DelMar Pharmaceuticals Presents Additional Data on the Potential of VAL-083 in the Treatment of Temozolomide-Resistant Glioblastoma Multiforme 2DelMar Pharmaceuticals Presents Additional Data on the Potential of VAL-083 in the Treatment of Temozolomide-Resistant Glioblastoma Multiforme 3DelMar Pharmaceuticals Presents Additional Data on the Potential of VAL-083 in the Treatment of Temozolomide-Resistant Glioblastoma Multiforme 4DelMar Pharmaceuticals Presents Additional Data on the Potential of VAL-083 in the Treatment of Temozolomide-Resistant Glioblastoma Multiforme 5
... 6, 2010 The Novartis Pharmaceutical Corporation ("Novartis") ... control and tumor reduction in extensively pretreated Hodgkin ... refractory after an autologous stem cell transplant, according ... trial presented today(1). In this pivotal ...
... 2010 Direct Relief International announced ... medical supplies to assist cholera patients in Haiti. The products ... JUH is the main public hospital for the entire northern ... also be distributed to the numerous cholera treatment units (CTUs) ...
Cached Medicine Technology:Novartis Phase II LBH589 data show substantial disease control and tumor reduction in extensively pretreated Hodgkin lymphoma patients 2Novartis Phase II LBH589 data show substantial disease control and tumor reduction in extensively pretreated Hodgkin lymphoma patients 3Novartis Phase II LBH589 data show substantial disease control and tumor reduction in extensively pretreated Hodgkin lymphoma patients 4Novartis Phase II LBH589 data show substantial disease control and tumor reduction in extensively pretreated Hodgkin lymphoma patients 5Novartis Phase II LBH589 data show substantial disease control and tumor reduction in extensively pretreated Hodgkin lymphoma patients 6Novartis Phase II LBH589 data show substantial disease control and tumor reduction in extensively pretreated Hodgkin lymphoma patients 7CSL Behring Medical Product Donation Helps Meet Critical Need for Ongoing Cholera Relief Effort in Haiti 2CSL Behring Medical Product Donation Helps Meet Critical Need for Ongoing Cholera Relief Effort in Haiti 3
(Date:5/29/2015)... NY (PRWEB) May 29, 2015 The ... as well as a number of specific concerns within, ... stigma reduction and mental health in the workplace. We ... mental health. The campaign also brings special focus to ... individuals to speak up and seek help from healthcare ...
(Date:5/29/2015)... Ca (PRWEB) May 29, 2015 ... pain consultations with specialists, physical therapy, and injections ... experiencing mid back and/or lower back pain, Healthpointe ... epidural injections for herniated discs, disc protrusions and ... . , Healthpointe’s team of renowned surgeons ...
(Date:5/29/2015)... 2015 The Global Allopurinol Industry ... on the current state of the Allopurinol industry.With ... statistics on the state of the industry and ... for companies and individuals interested in the market. ... industry including definitions, classifications, applications and industry chain ...
(Date:5/29/2015)... Florida (PRWEB) May 29, 2015 Designed ... Bodybuilding.com teamed up to create an all new, exclusive ... are a formulated with the latest and greatest, high ... and proven to be effective. The 24/7 Series can ... to cross-fitters and even the casual fitness enthusiasts. There ...
(Date:5/29/2015)... Javlin continues to fulfill its worldwide growth ... larger team, with the intention to better serve the ... the U.S. and Canada. , Javlin Inc., the wholly ... in 2014 with its strongest earnings to date, based ... CloverETL. To accelerate further progress and ensure exceptional customer ...
Breaking Medicine News(10 mins):Health News:Mediaplanet Brings Activism to Those Living with Mental Illness in Bew “Mental Health Awareness” Campaign 2Health News:Healthpointe’s Pain Management Specialists Now Providing Lumbar Epidural Injections in Los Angeles County 2Health News:Healthpointe’s Pain Management Specialists Now Providing Lumbar Epidural Injections in Los Angeles County 3Health News:Allopurinol Industry (Global, China) 2015 Research Analysis and 2020 Forecasts 2Health News:BPI Sports and Bodybuilding.com Partner Up to Bring an Innovative New Line of Supplements 2Health News:BPI Sports and Bodybuilding.com Partner Up to Bring an Innovative New Line of Supplements 3Health News:Growth of Data Integration Platform CloverETL Continues in North America 2
... Workers Seeking Ground Rules for Union Election Say Hospital System Fails ... ... 27 Hundreds of faith leaders,elected officials and other community members ... and procession outside the,system,s headquarters on Saturday, where they called for ...
... Discussed at American Society of Plastic Surgeons Annual ... ... fact or fiction, non- and minimally-invasive techniques to,remove fat are making headlines. ... surgery? Plastic surgeons will discuss if,these are cutting edge new discoveries or ...
... 27 The American Red Cross,Blood Services national system ... into southern California to help stabilize the blood,supply in ... Red Cross has provided nearly 2,000 blood products to ... Blood Services Region.,Blood drives in southern California have been ...
... 8 and 9, 2007, PENSACOLA, Fla., Oct. ... to be a major sponsor for this Summit. ... in,healthcare, the Department of Defense, Veterans Administration, research,organizations ... solutions,for strategic health intelligence. This summit represents the ...
... WITH ... , http://www.mccormickandschmicks.com/index.cfm?fuseaction=content.display Adult-Care.Org, Inc. ... to promote Better Choice, Healthy Food and a Healthy ... reach a new generation of consumers., PORTLAND, Ore., Oct. ...
... of Estrostep Fe Under TriLegest(TM) Fe ... ... Barr,Pharmaceuticals, Inc. (NYSE: BRL ) today announced that its subsidiary, ... (FDA) for its Abbreviated New Drug Application (ANDA) to,manufacture and market ...
Cached Medicine News:Health News:Healthcare Workers to St. Joseph Health System: Fair Election Agreement Now 2Health News:Non-Invasive Fat-Melting Procedures - Hype or Reality? 2Health News:American Red Cross Blood Services Supports Blood Needs of Southern California 2Health News:Cogon Systems Supports the Pensacola Bay Area Chamber of Commerce with the Strategic Health Intelligence Summit 2Health News:Barr's Generic Version of Estrostep(R) Fe Tablets Approved 2Health News:Barr's Generic Version of Estrostep(R) Fe Tablets Approved 3Health News:Barr's Generic Version of Estrostep(R) Fe Tablets Approved 4
... EC 350 consists of two modular units. ... surface and reaches a temperature of -15C. ... reservoir, heated dispenser nozzle, heated work surface, ... separate heated compartments for molds and cassettes. ...
... The exclusive mountant media dispensing ... air bubbles under the coverglass. ... interface with most automated staining ... to load, pre-filled coverglass and ...
... robotic system for spinal procedures. The SpineAssist ... highly accurate, easy-to-use solution that enables surgery ... minimum intervention. SpineAssist currently answers a growing ... guidance devices in pedicle screw insertion for ...
Hydrophobic Acrylic Intraocular Lens, AC depth: 5.3....
Medicine Products: